What Happened?
Secaucus, NJ-based Quest Diagnostics Resigned David Gulli as Senior Director and Head of Software Quality Assurance and Test Engineering
About the Company
Quest Diagnostics Incorporated is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company has about 42,000 employees, serves approximately ½ of all physicians & hospitals in the U.S., & reported 2011 revenues of $7.5 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,000 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals.
About the Person
David Gulli is Vice President of Software Quality Assurance at CNSI. Previously, David held various senior IT leadership roles in the industry.
Info Source
News
Short Profile